Cedars-Sinai investigators may have figured out why certain immunosuppressive treatments don't work well in rheumatoid ...

Lifileucel showed a 31.4% objective response rate and a median duration of response of 36.5 months in advanced melanoma patients. The median overall survival was 13.9 months, with adverse events ...

Greenland has changed quickly in the past 25 years. Along with new foods, jobs and habits has come a sharp rise in type 2 ...

ORLANDO -- Anti-interleukin (IL)-5 receptor alpha monoclonal antibody benralizumab (Fasenra) reduced flares in ...

The right online broker can help you execute your investment strategy and make trading cheap stocks seamless. Take a look at some of Benzinga’s favorites. You have found stocks to buy now cheap, but ...

Bacteria, viruses and fungi that colonize the body — including some that live directly on eye surfaces — can have an ...

Among adults and adolescents with cystic fibrosis starting triple therapy for the first time, inflammatory markers fell and ...

As biologic options have expanded for the treatment of chronic spontaneous urticaria (CSU), the question of which one works ...

NewsNation’s Chris Cuomo will host an hour-long special program, “Killing Cancer,” to examine a potentially groundbreaking ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

Adults with IBD who achieved delayed remission by week 30 after starting advanced therapy had similar 1-year clinical and endoscopic outcomes as early remitters.

撰文丨王聪编辑丨王多鱼排版丨水成文卵巢癌（Ovarian ...